Table 1 Demographic, clinical and optical coherence tomography (OCT) findings of the study participants:
Variable | Value |
|---|---|
No. of patients (n) | 93 |
No. of eyes (n) | 109 |
Age (years) | 65.34 ± 8.90 |
Males: Females | 74:19 |
Duration of DM (years) | 16.39 ± 7.88 |
HbA1c (%) | 8.4 ± 0.974 |
Coronary artery disease (n, %) | 7 (8) |
Hypertension (n, %) | 49 (53) |
Hypercholesterolemia (n, %) | 3 (3) |
Chronic kidney disease (n, %) | 4 (4) |
Cerebrovascular accident (n, %) | 2 (2) |
No systemic illness (n, %) | 39 (42) |
Moderate NPDR (n, %) | 26 (24) |
Severe NPDR (n, %) | 38 (35) |
PDR (n, %) | 45 (41) |
Visual acuity (ETDRS letters) | 47.14 ± 17.1 |
Central subfield thickness (microns) | 516.0 ± 141.8 |
No. of eyes who received intravitreal injections for DME before 24 weeks from treatment advice (n, %) | 94 (86) |
No. of eyes who received intravitreal injections for DME at or after 24 weeks from treatment advice (n, %) | 15 (14) |